Atovaquone (Mepron) plus cholestyramine (Questran) in patients who are co-infected with Babesia Microti and Borrelia burgdorferi and refractory to antibiotics and cholestyramine alone. American Society of Tropical Medicine 51st annual meeting, 11/11/02, Denver, Colo, (abst ) AJTMH
Shoemaker RC, House D, van Kempen A +1 more2002
GastrointestinalImmune/InnateNeurological
Lyme & Co-Infections
Summary
No abstract is available for this paper. It was published in 2002 by Shoemaker RC and colleagues. CIRS Nexus tags it under Lyme & Co-Infections, Gastrointestinal, Immune/Innate, Neurological.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- Herbal Therapeutics for CIRS Biomarkers in Autism Spectrum Disorders: A Mechanistic and Molecular Approach for Neuroimmune Pathology in PediatricsMedical Research Archives · 2026 · 4 shared tags
- Chronic Fatiguing Illnesses: Entering the era of new biomarkers and therapiesInternal Medicine Review · 2017 · 4 shared tags
- Exploring Structured Camel Milk Therapy Alongside an Individualised Botanical Support Protocol to Facilitate Immune Modulation in a Child Diagnosed with PANS/PANDAS Co-Morbid with Lyme Disease and AutismJournal of Camel Practice and Research · 2025 · 4 shared tags
- TUBB1, TUBA4A and MAPK as Indicators of Die-Back Degenerative Central Nervous System Disease in Patients Sickened by Specific Exposure to the Interior Environment of Water- Damaged BuildingsMedical Research Archives · 2023 · 4 shared tags
- Autism Spectrum Disorders and Lyme Disease: Exploring Shared Neuro-Inflammatory and Immune PathwaysMedical Research Archives · 2025 · 4 shared tags
- Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illnessThe Pediatric Infectious Disease Journal · 1997 · 4 shared tags